Showing results (1-10 of 55) with videos related to
Sort By:
Pageof 6
Best Practice & Research. Clinical Haematology|June 11, 2011
Radioimmunotherapy in follicular lymphomaTim Illidge, Franck MorschhauserLeukemia & Lymphoma|April 10, 2008
Current treatment approaches for diffuse large B-cell lymphomaTim Illidge, Shaun TolanLeukemia & Lymphoma|July 8, 2008
How have outcomes for patients with follicular lymphoma changed with the addition of monoclonal antibodies?Tim Illidge, Clara ChanThe Journal of Pharmacy and Pharmacology|July 23, 2008
New insights into the mechanisms of action of radioimmunotherapy in lymphomaAndrei Ivanov, Ruth Swann, Tim IllidgeCurrent Opinion in Urology|August 24, 2016
Immunotherapy with radiotherapy in urological malignanciesShaveta Mehta, Tim Illidge, Ananya ChoudhuryCancer|July 11, 2006
Recommendations for the use of yttrium-90 ibritumomab tiuxetan in malignant lymphomaOliver Weigert, Tim Illidge, Wolfgang Hiddemann, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
Radiation therapy with tositumomab (B1) anti-CD20 monoclonal antibody initiates extracellular signal-regulated kinase/mitogen-activated protein kinase-dependent cell death that overcomes resistance to apoptosisAndrey Ivanov, Sergei Krysov, Mark S Cragg, et al.Expert Opinion on Biological Therapy|September 6, 2014
Update on obinutuzumab in the treatment of B-cell malignanciesTim Illidge, Eleanor J Cheadle, Claire Donaghy, et al.Cancer Research|February 7, 2007
Microscopic intratumoral dosimetry of radiolabeled antibodies is a critical determinant of successful radioimmunotherapy in B-cell lymphomaYong Du, Jamie Honeychurch, Martin Glennie, et al.Pageof 6